However, we found that ORY induced ACSL4 elevation in both LSD1 inhibitor-sensitive and -insensitive cell lines, indicating that ACSL4 is not a predictive marker for ferroptosis induced by LSD1 inhibitors in NSCLC. The gene discussed is KDM1A; the disease is non-small cell lung carcinoma.